Skip to main content
Fernando Ovalle, MD, Endocrinology, Birmingham, AL

FernandoOvalleMD

Endocrinology Birmingham, AL

Diabetes

Professor of Medicine and Director, Division of Endocrinology Diabetes & Metabolism, University of Alabama at Birmingham School of Medicine

Dr. Ovalle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ovalle's full profile

Already have an account?

  • Office

    1717 6th Ave S
    Birmingham, AL 35233
    Phone+1 800-822-8816
    Fax+1 205-975-9304

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1997
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1995
  • Universidad Autonoma de Nuevo Leon
    Universidad Autonoma de Nuevo LeonClass of 1989

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1997 - 2024
  • MI State Medical License
    MI State Medical License 1994 - 1998
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Internal Medicine in the Subspecialty of Endocrinology, Diabetes & Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Verapamil and Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes  
    Anish J Patel, Fernando Ovalle, Nature

Press Mentions

  • 8 Warning Signs of Type 2 Diabetes
    8 Warning Signs of Type 2 DiabetesApril 2nd, 2023
  • What Are Continuous Glucose Monitors, and How Can They Help You?
    What Are Continuous Glucose Monitors, and How Can They Help You?March 29th, 2023
  • An Oral Medication Shows Benefits Treating Type 1 Diabetes for at Least Two Years After Diagnosis
    An Oral Medication Shows Benefits Treating Type 1 Diabetes for at Least Two Years After DiagnosisMarch 3rd, 2022
  • Join now to see all

Grant Support

  • The Risk Of The Polycystic Ovary Syndrome In Women With Type 2 Diabetes MellitusNational Center For Research Resources2005
  • Adrenicortical Steroidogenesis In Euandrogenic And Hyperandrogenic WomenNational Center For Research Resources2005
  • The Risk Of The Polycystic Ovary Syndrome In WomenNational Center For Research Resources2004
  • Adrenicortical Steroidogen. In Eu/Hyperandrogenic WomenNational Center For Research Resources2004
  • Diabetes Prevention Trial: Type I (Dpt-1)National Center For Research Resources2000

Other Languages

  • Spanish